戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ychiatric symptoms were assessed through The Neuropsychiatric Inventory.
2 tric symptoms and behaviours measured by the Neuropsychiatric Inventory.
3 detailed neuropsychological testing, and the Neuropsychiatric Inventory.
4    Behavioral changes were assessed with the Neuropsychiatric Inventory.
5 Daily Living Activities in Dementia, and the Neuropsychiatric Inventory.
6  Frontal Behavioural Inventory (22%) and the Neuropsychiatric Inventory (28%) -- suggesting that thes
7 mentia: -5.39 [95% CI, -10.73 to -0.05], and Neuropsychiatric Inventory: -4.25 [95% CI, -8.37 to -0.1
8 ychiatric examinations and were rated on the Neuropsychiatric Inventory, a widely used method for asc
9 ADNC/LATE-NC was associated with lower total Neuropsychiatric Inventory and agitation factor scores t
10 ET asymmetry and behavior assessed using the neuropsychiatric inventory and composite scores for memo
11                                 Longitudinal Neuropsychiatric Inventory and psychotropic medication p
12  hallucinations and agitation domains of the Neuropsychiatric Inventory) and extrapyramidal side effe
13    Behavioral changes were assessed with the Neuropsychiatric Inventory, and alterations in caregiver
14  42 interviews, 28 patient medical notes, 27 neuropsychiatric inventory, and documentary review); 3)
15 hange Plus Caregiver Input (CIBIC-Plus), the Neuropsychiatric Inventory, and the Behavioral Rating Sc
16 nosis of probable frontotemporal dementia, a Neuropsychiatric Inventory apathy score of 2 or higher,
17 ocin every third day resulted in an improved Neuropsychiatric Inventory apathy score, with an estimat
18 mary outcome was difference in the change in Neuropsychiatric Inventory apathy scores for oxytocin ve
19 howed weak to moderate correlations with the Neuropsychiatric Inventory-Apathy subscale (r = 0.39-0.6
20        The verbal word learning task and the neuropsychiatric inventory assessed memory functioning a
21 se of standardized assessment tools like the Neuropsychiatric Inventory can assist with qualifying an
22 ores for the Neuropsychiatric Inventory, the Neuropsychiatric Inventory Caregiver Distress Scale, or
23 s in caregiver distress were measured by the Neuropsychiatric Inventory distress scale.
24 ehavioural abnormalities, as measured by the Neuropsychiatric Inventory, in 148 patients with dementi
25 ry end point was change from baseline on the Neuropsychiatric Inventory (NPI) Agitation/Aggression do
26 ations between the 12 symptom domains in the Neuropsychiatric Inventory (NPI) and relapse in the firs
27 hy MBI, non-MBI NPS and no-NPS) based on the Neuropsychiatric Inventory (NPI) or NPI-Questionnaire (N
28 ence of delusions and hallucinations via the Neuropsychiatric Inventory (NPI) questionnaire.
29 uent and/or severe apathy as measured by the Neuropsychiatric Inventory (NPI) were included.
30 Mansfield Agitation Inventory (CMAI) and the Neuropsychiatric Inventory (NPI), ability to complete ac
31  PET), Mini-Mental State Examination (MMSE), Neuropsychiatric Inventory (NPI), and Everyday Cognition
32 neuropsychiatric symptoms as measured by the neuropsychiatric inventory (NPI).
33 chiatric assessment was undertaken using the Neuropsychiatric Inventory (NPI).
34 sychiatric symptoms were evaluated using the Neuropsychiatric Inventory (NPI).
35 opsychiatric symptom domains assessed by the Neuropsychiatric Inventory (NPI).
36     A total of 824 individuals completed the Neuropsychiatric Inventory (NPI); 362 were classified as
37 opsychiatric outcomes were measured with the Neuropsychiatric Inventory (NPI, 0-120 points) and the A
38 ain outcomes were neuropsychiatric symptoms (Neuropsychiatric Inventory [NPI]), caregiver burden (Ber
39 ons, and Delusions items (Core Total) of the Neuropsychiatric Inventory-Nursing Home version.
40 oral dementia improved apathy ratings on the Neuropsychiatric Inventory over 1 week and, in a randomi
41 in Mini-Mental State Examination (P =.22) or Neuropsychiatric Inventory (P =.32) ratings over time.
42  13.9% AD) who had completed sleep measures (Neuropsychiatric Inventory), PET Abeta data, and resting
43     Primary outcomes were caregiver-reported Neuropsychiatric Inventory Questionnaire (NPI-Q) severit
44                      The primary outcome was Neuropsychiatric Inventory Questionnaire (NPI-Q) severit
45  severity score for behavioral change on the Neuropsychiatric Inventory Questionnaire (NPI-Q).
46 0 collection for participants among whom the Neuropsychiatric Inventory Questionnaire (NPIQ) was admi
47                                     Baseline Neuropsychiatric Inventory Questionnaire data were avail
48 onal/behaviour symptoms as assessed with the Neuropsychiatric Inventory questionnaire or across neuro
49                                              Neuropsychiatric Inventory Questionnaire score.
50 ymptom (NOSYMP; n = 106) groups based on the Neuropsychiatric Inventory Questionnaire.
51 the Hamilton Depression Rating Scale and the Neuropsychiatric Inventory Questionnaire.
52  to frequency of behavioural symptoms on the Neuropsychiatric Inventory-Questionnaire and severity of
53 es indicated that depressive symptoms on the Neuropsychiatric Inventory-Questionnaire were less commo
54                                    Using the Neuropsychiatric Inventory-Questionnaire, MBI+ status wa
55 Alzheimer's disease, were evaluated with the Neuropsychiatric Inventory-Questionnaire, the 15-item Ge
56                                              Neuropsychiatric Inventory scores also indicated faster
57                                              Neuropsychiatric Inventory scores worsened with placebo,
58 mg/day of galantamine had no change in total Neuropsychiatric Inventory scores.
59 matic or symptomatic at baseline, had better Neuropsychiatric Inventory subscale scores than did pati
60 r in behavioural severity as measured by the Neuropsychiatric Inventory; supporting the original clas
61 acebo and donepezil groups in scores for the Neuropsychiatric Inventory, the Neuropsychiatric Invento
62 ical Dementia Rating scale sum-of-boxes, the Neuropsychiatric Inventory, the Quality of Life-AD, and
63 es in Dementia (to assess function), and the Neuropsychiatric Inventory (to assess behavioral and psy
64 vement with olanzapine or risperidone on the Neuropsychiatric Inventory total score, risperidone on t
65 (FTLD-CDR), Functional Assessment Scale, and Neuropsychiatric Inventory using regression models.
66                   Assessment by means of the neuropsychiatric inventory was made at baseline, and aga
67 urs from the brief questionnaire form of the Neuropsychiatric Inventory were assessed.